Suppr超能文献

[肾盂及输尿管肿瘤的临床研究]

[A clinical study on tumor of the renal pelvis and the ureter].

作者信息

Yui Y, Nakajima H, Tsuboi N, Akimoto M

出版信息

Hinyokika Kiyo. 1985 Feb;31(2):231-7.

PMID:4013941
Abstract

The 39 cases of renal pelvic and ureteral tumors treated in our hospital from 1974 to 1983, were reviewed retrospectively. The 39 cases included 15 renal pelvic tumors, 21 ureter tumors and 3 ureteropelvic tumors. The incidence of these tumors was 0.15% among all new outpatients. Sex distribution was 25 males to 14 females, and mean age was 65.2 years old. Hematuria was the most frequent initial symptom and chief complaint. Of the patients, 28.6% had come to our hospital within one month after their initial symptoms appeared. "Filling defect", an important finding of IVP and RP, was revealed most frequently. The positive rate of urine cytology was 33.4%. Histological examination revealed 14 transitional cell carcinoma and 1 papilloma of 15 renal pelvic tumors and 19 transitional cell carcinoma, 1 polyp and 1 metastatic adenocarcinoma of 21 ureter tumors. Operative therapy was performed on 36 patients; 26 by nephroureterectomy with partial cystectomy. Vesical recurrence rate was 18.9%. The 5-year survival rate was 37.4% on renal pelvic tumor and 40.7% on ureter tumor. The factors, high grade, high stage, and ureteropelvic double tumor, which reflect the specificity of the malignant potential, also affected prognosis. In conclusion, post-operative adjuvant therapy was thought to be valuable in the near future.

摘要

回顾性分析了我院1974年至1983年收治的39例肾盂及输尿管肿瘤患者。39例患者中,肾盂肿瘤15例,输尿管肿瘤21例,输尿管肾盂肿瘤3例。这些肿瘤在所有新门诊患者中的发病率为0.15%。性别分布为男性25例,女性14例,平均年龄65.2岁。血尿是最常见的首发症状和主要主诉。其中,28.6%的患者在出现初始症状后1个月内来我院就诊。静脉肾盂造影(IVP)和逆行肾盂造影(RP)的重要表现“充盈缺损”最为常见。尿细胞学检查阳性率为33.4%。组织学检查显示,15例肾盂肿瘤中有14例移行细胞癌和1例乳头状瘤,21例输尿管肿瘤中有19例移行细胞癌、1例息肉和1例转移性腺癌。36例患者接受了手术治疗;26例行肾输尿管切除术加部分膀胱切除术。膀胱复发率为18.9%。肾盂肿瘤的5年生存率为37.4%,输尿管肿瘤为40.7%。反映恶性潜能特异性的高分级、高分期和输尿管肾盂双肿瘤等因素也影响预后。总之,术后辅助治疗在不久的将来被认为是有价值的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验